EU law of competition and trade in the pharmaceutical sector
著者
書誌事項
EU law of competition and trade in the pharmaceutical sector
（Elgar competition law and practice）
Edward Elgar, c2019
- : cased
- タイトル別名
-
European Union law of competition and trade in the pharmaceutical sector
大学図書館所蔵 件 / 全3件
-
該当する所蔵館はありません
- すべての絞り込み条件を解除する
注記
Includes bibliographical references and index
内容説明・目次
内容説明
This book provides a systematic analysis of the law and practice of EU competition/antitrust law and trade regulation in the pharmaceutical sector. Authored by leading private practitioners, economists, scholars and high-profile competition enforcers, this work provides valuable insider knowledge on the application of competition law and policies to the pharmaceutical industry.
Key features include:
Extensive commentary on the legislation and the latest case law and administrative precedents in the pharmaceutical sector, at both EU and national level
Coverage of various key developments including the recent pay-for-delay antitrust investigations, the perennial issues around parallel trade, and an examination of mergers among pharmaceutical companies and medical devices manufacturers
In-depth analysis of topics commonly raised in the pharmaceutical sector including: pricing policies, IP life-cycle management, IP licensing and horizontal cooperation agreements
Key economic and business perspectives to accompany legal analysis, providing the reader with a rounded view of the subject matter.
This book will be a useful resource for lawyers and in-house counsel active in the pharmaceutical sector. The information and analysis provided will prepare readers to take on cases and drive the antitrust review of transactions and agreements within the industry. Researchers, economists and civil servants with an interest in competition law and trade regulation can also benefit from the practical insights provided therein.
目次
Contents:
1. Competition Law and Pharma: An Economic Perspective
Benoit Durand
2. Reverse Payments: an EU and U.S. Perspective
Frank Maier-Rigaud, Nathan Blalock and Oliver Gannon
3. Article 101 TFEU: Horizontal Cooperation Agreements in the Pharmaceutical Sector
Soledad Blanco Thomas, Lilia Luchianov and Thomas Weck
4. The Competitive Assessment of IP Licensing Agreements in the Pharmaceutical Sector
Pierre Moullet
5. Article 102 TFEU: Patent filings as an abuse of dominant position after "AstraZeneca": the patent / antitrust interface under a new perspective
Francisco Hernandez
6. Mergers in the Pharmaceutical Sector
Pablo Figueroa and Alejandro Guerrero
7. Mergers in the Medical Devices Sector
Jan Heithecker
8. Antitrust Practices in Pharmaceutical Public Procurement
Antonio Minho Lopez
9. EU Trade Law and Pharmaceuticals
Pascale Hecker
10. The Pharmaceutical Sector and Parallel Trade
Edurne Navarro Varona and Cristina Caballero
11. Free Movement and Competition in the European Market for Pharmaceuticals
Pedro Caro de Sousa
12. IP Law and Pharmaceuticals: Patents and Supplementary Protection Certificates in the Pharmaceutical Sector
Rais Amils
13. The EU Regulatory Framework for Medical Products for Human Use
Marc Martens and Nicolas Carbonnelle
14. Antitrust and the Pharmaceutical Industry in the United States
George A. Hay
15. UK Competition and Trade in the Pharma Sector
Paula Riedel
16. Competition law and Pharma: China
Andrew Foster
17. Competition Law and Pharma: Spain
Helmut Brokelmann and Mariarosaria Ganino
18. The Application of Competition Law in the Pharmaceutical Sector: Challenges for BRICS
Maria Ioannidou and Ioannis Kokkoris
19. Product Hopping: The U.S. Approach
Michael A. Carrier
20. Marketing data in the Pharmaceutical Sector: a competition law consideration
Pedro Callol
Index
「Nielsen BookData」 より